glp 1 and eating disorders Experts express alarm that GLP-1 RAs may trigger or worsen disorders. But is there any role they might play in binge eating disorder? how can clinicians protect patients from risk? Glucagon-like peptide-1 medicines in neurological
Description
Pfizer was the first major drug maker to reach a deal with Trump, slashing prices for some medicines by up to 85% on the TrumpRx site

The safer takeaway is that GLP1 medications may affect some of the same systems involved in reward, appetite, metabolism, and self-regulation

doi: 10.3390/ijerph18084381

Another triple agonist (HM15211) is undergoing phase 1 clinical trials with no published data so far

Red orange extract Very niche, mostly appears in premium or antioxidant-focused blends
A total 1 g of RNA was used for the reaction
